The Multiple Myeloma Channel is supported with funding from BMS (Gold) and Legend Biotech (Bronze).
VJHemOnc is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
EHA 2022 | The use of single-cell RNA sequencing to analyze patient response to CAR-T
Juan Du
• 13 Jun 2022
Juan Du, MD, Changzheng Hospital, The Second Military Medical University, Shanghai, China, briefly discusses a study which investigated the use of single-cell RNA sequencing to analyze patient response to CAR-T therapy, and the value of using single-cell sequencing in future studies. This interview took place at the European Hematology Association (EHA) Congress 2022 held in Vienna, Austria.
